KLOW 80mg

$160.00

Multi peptide blend studied for synergistic tissue repair pathways

 

Title Range Discount
10% discount 2 10%
15% discount 3 - 5 15%
20% discount 6 - 10 20%
SKU KLOW-80-3287 Category

Please login to view products

Login

Description

Overview: KLOW 80 mg is a high-purity multi-peptide research blend supplied in lyophilized (freeze-dried) powder form for laboratory applications. It is composed of multiple bioactive peptides typically including GHK-Cu, BPC-157, TB-500, and KPV, combined to support multi-pathway research models. In controlled laboratory settings, this blend is studied for its role in cellular signaling interactions, extracellular matrix modulation, inflammatory pathway regulation, and tissue response mechanisms. Researchers use multi-component blends like KLOW to evaluate synergistic peptide activity, comparative pathway effects, and stability in combined formulations. Each vial is manufactured under strict quality standards and labeled for Research Use Only (RUO). This product is strictly not intended to diagnose, treat, cure, or prevent any disease and is not approved for human or veterinary use. It is intended exclusively for qualified laboratory research purposes.

Product Overview

Form: Lyophilized Peptide Blend (80 mg Vial)
Category: Research Peptide Blend
Recommended Use: For laboratory and research purposes only. Not intended for human or veterinary use.
Storage & Handling: Store refrigerated (2°C–8°C). Protect from heat, light, and moisture. Keep vial sealed until ready for research use. After reconstitution, handle according to standard laboratory sterility and stability protocols.

Product Information

Mg: 80MG
Vial size: 3ml
Kit UPC codes: 693793813287
Bottle UPC codes: 619364371437
SKU: KLOW-80-3287
LOT Q2: 634-677
BATCH Q2: RP-29187453
EXPERATION Q2: 03/2028

Related Products

Please login to view products

Login

Please login to view products

Login

Please login to view products

Login

Are you over 21 ?

Are you must be 21 years old to access the site. By clicking “YES”.